Establishment of a humanized apl model via the transplantation of PML-rara-transduced human common myeloid progenitors into immunodeficient mice

PLoS ONE

Volumn 9, Issue 11, 2014, Pages

  Matsushita, Hiromichi ^a,b   Yahata, Takashi ^a,b   Sheng, Yin ^a   Nakamura, Yoshihiko ^a   Muguruma, Yukari ^a   Matsuzawa, Hideyuki ^a,b   Tanaka, Masayuki ^b   Hayashi, Hideki ^b   Sato, Tadayuki ^b   Damdinsuren, Anar ^a   Onizuka, Makoto ^a   Ito, Mamoru ^c   Miyachi, Hayato ^a   Pandolfi, Pier Paolo ^d   Ando, Kiyoshi ^a,b  

^a TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TOKAI UNIVERSITY   (Japan)

^c CENTRAL INSTITUTE FOR EXPERIMENTAL ANIMALS   (Japan)

^d HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD33 ANTIGEN; CD34 ANTIGEN; HLA DR ANTIGEN; MICROSOMAL AMINOPEPTIDASE; STEM CELL FACTOR RECEPTOR; CD45 ANTIGEN; ONCOPROTEIN; PROMYELOCYTIC LEUKEMIA-RETINOIC ACID RECEPTOR ALPHA FUSION ONCOPROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD34 SELECTION; CELL TRANSPLANTATION; CONTROLLED STUDY; CYTOPLASM; GENE; GENE EXPRESSION; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; IN VIVO STUDY; LEUKEMIA CELL; LEUKEMOGENESIS; MOUSE; MYELOID PROGENITOR CELL; NONHUMAN; PML RARA GENE; PROMYELOCYTIC LEUKEMIA; PROTEIN EXPRESSION; UMBILICAL CORD BLOOD; ANIMAL; CELL DIFFERENTIATION; CYTOLOGY; DISEASE MODEL; FETUS BLOOD; GENETICS; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; METABOLISM; MORTALITY; NONOBESE DIABETIC MOUSE; PATHOLOGY; SURVIVAL RATE; XENOGRAFT;

ANIMALS; ANTIGENS, CD34; ANTIGENS, CD45; CELL DIFFERENTIATION; DISEASE MODELS, ANIMAL; FETAL BLOOD; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HUMANS; LEUKEMIA, PROMYELOCYTIC, ACUTE; MICE; MICE, INBRED NOD; ONCOGENE PROTEINS, FUSION; SURVIVAL RATE; TRANSPLANTATION, HETEROLOGOUS;

EID: 84928541987     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0111082     Document Type: Article

References (45)

1. Lowenberg B (2008) Acute myeloid leukemia: the challenge of capturing disease variety. Hematology Am Soc Hematol Educ Program: 1-11.
2. Lapidot T, Sirard C, Vormoor J, Murdoch B, Hoang T, et al. (1994) A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature 367: 645-648.
3. Bonnet D, Dick JE (1997) Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med 3: 730-737.
4. Grimwade D, Enver T (2004) Acute promyelocytic leukemia: where does it stem from? Leukemia 18: 375-384.
5. Hope KJ, Jin L, Dick JE (2004) Acute myeloid leukemia originates from a hierarchy of leukemic stem cell classes that differ in self-renewal capacity. Nat Immunol 5: 738-743.
6. Dick JE (2008) Stem cell concepts renew cancer research. Blood 112: 4793- 4807.
7. Becker MW, Jordan CT (2011) Leukemia stem cells in 2010: current understanding and future directions. Blood Rev 25: 75-81.
8. de The H, Chen Z (2010) Acute promyelocytic leukaemia: novel insights into the mechanisms of cure. Nat Rev Cancer 10: 775-783.
9. Paietta E (2003) Expression of cell-surface antigens in acute promyelocytic leukaemia. Best Pract Res Clin Haematol 16: 369-385.
10. Ito M, Hiramatsu H, Kobayashi K, Suzue K, Kawahata M, et al. (2002) NOD/SCID/gamma(c)(null) mouse: An excellent recipient mouse model for engraftment of human cells. Blood 100: 3175-3182.
11. Yahata T, Ando K, Nakamura Y, Ueyama Y, Shimamura K, et al. (2002) Functional human T lymphocyte development from cord blood CD34+ cells in nonobese diabetic/Shi-scid, IL-2 receptor gamma null mice. J Immunol 169: 204-209.
12. Patel S, Zhang Y, Cassinat B, Zassadowski F, Ferre N, et al. (2012) Successful xenografts of AML3 samples in immunodeficient NOD/shi-SCID IL2Rgamma(-/-) mice. Leukemia 26: 2432-2435.
13. Guibal FC, Alberich-Jorda M, Hirai H, Ebralidze A, Levantini E, et al. (2009) Identification of a myeloid committed progenitor as the cancer-initiating cell in acute promyelocytic leukemia. Blood 114: 5415-5425.
14. Wojiski S, Guibal FC, Kindler T, Lee BH, Jesneck JL, et al. (2009) PMLRARalpha initiates leukemia by conferring properties of self-renewal to committed promyelocytic progenitors. Leukemia 23: 1462-1471.
15. Brown D, Kogan S, Lagasse E, Weissman I, Alcalay M, et al. (1997) A PMLRARalpha transgene initiates murine acute promyelocytic leukemia. Proc Natl Acad Sci U S A 94: 2551-2556.
16. Grisolano JL, Wesselschmidt RL, Pelicci PG, Ley TJ (1997) Altered myeloid development and acute leukemia in transgenic mice expressing PML-RAR alpha under control of cathepsin G regulatory sequences. Blood 89: 376-387.
17. He LZ, Tribioli C, Rivi R, Peruzzi D, Pelicci PG, et al. (1997) Acute leukemia with promyelocytic features in PML/RARalpha transgenic mice. Proc Natl Acad Sci U S A 94: 5302-5307.
18. Westervelt P, Lane AA, Pollock JL, Oldfather K, Holt MS, et al. (2003) Highpenetrance mouse model of acute promyelocytic leukemia with very low levels of PML-RARalpha expression. Blood 102: 1857-1865.
19. Grignani F, Valtieri M, Gabbianelli M, Gelmetti V, Botta R, et al. (2000) PML/RAR alpha fusion protein expression in normal human hematopoietic progenitors dictates myeloid commitment and the promyelocytic phenotype. Blood 96: 1531-1537.
20. Manz MG, Miyamoto T, Akashi K, Weissman IL (2002) Prospective isolation of human clonogenic common myeloid progenitors. Proc Natl Acad Sci U S A 99: 11872-11877.
21. Pear WS, Miller JP, Xu L, Pui JC, Soffer B, et al. (1998) Efficient and rapid induction of a chronic myelogenous leukemia-like myeloproliferative disease in mice receiving P210 bcr/abl-transduced bone marrow. Blood 92: 3780-3792.
22. Matsushita H, Scaglioni PP, Bhaumik M, Rego EM, Cai LF, et al. (2006) In vivo analysis of the role of aberrant histone deacetylase recruitment and RAR alpha blockade in the pathogenesis of acute promyelocytic leukemia. J Exp Med 203: 821-828.
23. Kawada H, Ando K, Tsuji T, Shimakura Y, Nakamura Y, et al. (1999) Rapid ex vivo expansion of human umbilical cord hematopoietic progenitors using a novel culture system. Exp Hematol 27: 904-915.
24. Yahata T, Takanashi T, Muguruma Y, Ibrahim AA, Matsuzawa H, et al. (2011) Accumulation of oxidative DNA damage restricts the self-renewal capacity of human hematopoietic stem cells. Blood 118: 2941-2950.
25. Rego EM, He LZ, Warrell RP Jr, Wang ZG, Pandolfi PP (2000) Retinoic acid (RA) and As2O3 treatment in transgenic models of acute promyelocytic leukemia (APL) unravel the distinct nature of the leukemogenic process induced by the PML-RARalpha and PLZF-RARalpha oncoproteins. Proc Natl Acad Sci U S A 97: 10173-10178.
26. Payton JE, Grieselhuber NR, Chang LW, Murakami M, Geiss GK, et al. (2009) High throughput digital quantification of mRNA abundance in primary human acute myeloid leukemia samples. J Clin Invest 119: 1714-1726.
27. Ando K, Yahata T, Sato T, Miyatake H, Matsuzawa H, et al. (2006) Direct evidence for ex vivo expansion of human hematopoietic stem cells. Blood 107: 3371-3377.
28. Schmidt M, Hoffmann G, Wissler M, Lemke N, Mussig A, et al. (2001) Detection and direct genomic sequencing of multiple rare unknown flanking DNA in highly complex samples. Hum Gene Ther 12: 743-749.
29. Dyck JA, Maul GG, Miller WH Jr, Chen JD, Kakizuka A, et al. (1994) A novel macromolecular structure is a target of the promyelocyte-retinoic acid receptor oncoprotein. Cell 76: 333-343.
30. Weis K, Rambaud S, Lavau C, Jansen J, Carvalho T, et al. (1994) Retinoic acid regulates aberrant nuclear localization of PML-RAR alpha in acute promyelocytic leukemia cells. Cell 76: 345-356.
31. Grignani F, Testa U, Rogaia D, Ferrucci PF, Samoggia P, et al. (1996) Effects on differentiation by the promyelocytic leukemia PML/RARalpha protein depend on the fusion of the PML protein dimerization and RARalpha DNA binding domains. EMBO J 15: 4949-4958.
32. Paietta E, Goloubeva O, Neuberg D, Bennett JM, Gallagher R, et al. (2004) A surrogate marker profile for PML/RAR alpha expressing acute promyelocytic leukemia and the association of immunophenotypic markers with morphologic and molecular subtypes. Cytometry B Clin Cytom 59: 1-9.
33. Welch JS, Ley TJ, Link DC, Miller CA, Larson DE, et al. (2012) The origin and evolution of mutations in acute myeloid leukemia. Cell 150: 264-278.
34. Welch JS, Yuan W, Ley TJ (2011) PML-RARA can increase hematopoietic selfrenewal without causing a myeloproliferative disease in mice. J Clin Invest 121: 1636-1645.
35. Wartman LD, Welch JS, Uy GL, Klco JM, Lamprecht T, et al. (2012) Expression and function of PML-RARA in the hematopoietic progenitor cells of CTSG-PML-RARA mice. Plos One 7: e46529.
36. Puccetti E, Ruthardt M (2004) Acute promyelocytic leukemia: PML/RARalpha and the leukemic stem cell. Leukemia 18: 1169-1175.
37. Ferrucci PF, Grignani F, Pearson M, Fagioli M, Nicoletti I, et al. (1997) Cell death induction by the acute promyelocytic leukemia-specific PML/RARalpha fusion protein. Proc Natl Acad Sci U S A 94: 10901-10906.
38. Grignani F, Ferrucci PF, Testa U, Talamo G, Fagioli M, et al. (1993) The acute promyelocytic leukemia-specific PML-RAR alpha fusion protein inhibits differentiation and promotes survival of myeloid precursor cells. Cell 74: 423- 431.
39. Collins SJ (2002) The role of retinoids and retinoic acid receptors in normal hematopoiesis. Leukemia 16: 1896-1905.
40. Du C, Redner RL, Cooke MP, Lavau C (1999) Overexpression of wild-type retinoic acid receptor alpha (RARalpha) recapitulates retinoic acid-sensitive transformation of primary myeloid progenitors by acute promyelocytic leukemia RARalpha-fusion genes. Blood 94: 793-802.
41. Thanopoulou E, Cashman J, Kakagianne T, Eaves A, Zoumbos N, et al. (2004) Engraftment of NOD/SCID-beta2 microglobulin null mice with multilineage neoplastic cells from patients with myelodysplastic syndrome. Blood 103: 4285-4293.
42. Kerbauy DM, Lesnikov V, Torok-Storb B, Bryant E, Deeg HJ (2004) Engraftment of distinct clonal MDS-derived hematopoietic precursors in NOD/SCID-beta2-microglobulin-deficient mice after intramedullary transplantation of hematopoietic and stromal cells. Blood 104: 2202-2203.
43. Muguruma Y, Matsushita H, Yahata T, Yumino S, Tanaka Y, et al. (2011) Establishment of a xenograft model of human myelodysplastic syndromes. Haematologica 96: 543-551.
44. Taussig DC, Vargaftig J, Miraki-Moud F, Griessinger E, Sharrock K, et al. (2010) Leukemia-initiating cells from some acute myeloid leukemia patients with mutated nucleophosmin reside in the CD34(-) fraction. Blood 115: 1976-1984.
45. Eppert K, Takenaka K, Lechman ER, Waldron L, Nilsson B, et al. (2011) Stem cell gene expression programs influence clinical outcome in human leukemia. Nat Med 17: 1086-1093.